Myelodysplastic Syndrome (MDS) Latest Advances

Find the Latest Research About Myelodysplastic Syndrome (MDS)

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20767 publications

A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.

A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.

Journal: Hematology (Amsterdam, Netherlands)
Published: April 13, 2026

5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisions.

5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisions.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026

Pulmonary Leukocytoclastic Vasculitis Associated with Myelodysplastic Syndrome: A Case Report.

Pulmonary Leukocytoclastic Vasculitis Associated with Myelodysplastic Syndrome: A Case Report.

Journal: Internal medicine (Tokyo, Japan)
Published: April 01, 2026

Site-specific methylation of SRSF2P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Site-specific methylation of SRSF2P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Journal: Science translational medicine
Published: April 01, 2026

Advances in molecular genetic research on Myelodysplastic syndrome

Advances in molecular genetic research on Myelodysplastic syndrome

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: April 01, 2026

A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

Journal: Leukemia & lymphoma
Published: March 30, 2026

Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes

Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 18, 2026

Mechanism of Sanzi Huangshi Pill in Treating MDS and Downregulating NRAS Gene Expression

Mechanism of Sanzi Huangshi Pill in Treating MDS and Downregulating NRAS Gene Expression

Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 18, 2026

Association between red cell distribution width to albumin ratio and all-cause mortality in critically ill patients with myelodysplastic syndrome: a retrospective cohort study.

Association between red cell distribution width to albumin ratio and all-cause mortality in critically ill patients with myelodysplastic syndrome: a retrospective cohort study.

Journal: Hematology (Amsterdam, Netherlands)
Published: March 17, 2026

Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)

Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 16, 2026

Advance in research on MIRAGE syndrome

Advance in research on MIRAGE syndrome

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: March 11, 2026
Showing 1-12 of 20,767

Last Updated: 04/28/2026